JENNIFER WARREN: Open Payments
NPI 1356707400 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,356 in 78 payments from 14 companies in 2025. Trend: 2023 $363 · 2024 $438 · 2025 $1,356
Food & beverage: $1,356
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $270 |
| ABBVIE INC. | 22 | $200 |
| Axsome Therapeutics, Inc. | 8 | $196 |
| Janssen Pharmaceuticals, Inc | 7 | $169 |
| Otsuka America Pharmaceutical, Inc. | 8 | $138 |
| Vanda Pharmaceuticals Inc. | 5 | $103 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Alkermes, Inc. | 2 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
Products named: CAPLYTA, VRAYLAR, Auvelity, INVEGA SUSTENNA, REXULTI, FANAPT, Jornay PM, ARISTADA.
Industry payments across MS — which companies pay providers there.
